Skip to content
Home/Companies/Biotech/MAIA Biotechnology
MB

MAIA Biotechnology

Biotech·United States·Exited 2022·Held 3yr

MAIA Biotechnology is a biotech company, headquartered in United States.

Entry
2019
Hold
3yr
Exit
2022
Est. EV
–

Who owns MAIA Biotechnology?

MAIA Biotechnology was owned by KIZOO Technology Capital through KIZOO Evergreen (Balance Sheet) (2007 vintage) from 2019 to 2022, exited via IPO.

Hand-verified · updated 2026-07-07

KIZOO Technology Capital
Investor
KIZOO Technology Capital
KIZOO Evergreen (Balance Sheet) · 2007 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2022

More from KIZOO Evergreen (Balance Sheet)

Other portfolio companies in the same fund.

Reservoir Neuroscience
Active
BiotechUnited States· 2024
MoglingBio
Active
BiotechGermany· 2022
Cellvie
Active
BiotechSwitzerland· 2021
Elastrin Therapeutics
Active
BiotechUnited States· 2021
Revel Pharmaceuticals
Active
BiotechUnited States· 2020
Cyclarity Therapeutics
Active
BiotechUnited States· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings